DCM
DAFNA Capital Management Portfolio holdings
AUM
$362M
1-Year Return
0.48%
This Quarter Return
-19.64%
1 Year Return
-0.48%
3 Year Return
+117.01%
5 Year Return
+181.93%
10 Year Return
+1,483.26%
AUM
$240M
AUM Growth
-$51.7M
(-18%)
Cap. Flow
+$13.5M
Cap. Flow
% of AUM
5.62%
Top 10 Holdings %
Top 10 Hldgs %
50.22%
Holding
91
New
10
Increased
29
Reduced
12
Closed
11
Top Buys
| 1 |
BPMC
Blueprint Medicines
BPMC
|
$6.13M |
| 2 |
Compugen
CGEN
|
$4.36M |
| 3 |
ARNA
Arena Pharmaceuticals Inc
ARNA
|
$3.39M |
| 4 |
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
|
$3.24M |
| 5 |
AGTC
Applied Genetic Technologies Corporation
AGTC
|
$2.63M |
Top Sells
| 1 |
ARQL
Arqule Inc
ARQL
|
$9.94M |
| 2 |
Cytokinetics
CYTK
|
$4.44M |
| 3 |
VYNE Therapeutics
VYNE
|
$3.7M |
| 4 |
AtriCure
ATRC
|
$2.65M |
| 5 |
ACHN
Achillion Pharmaceuticals, Inc.
ACHN
|
$2.65M |
Sector Composition
| 1 | Healthcare | 91.6% |
